fashion -WSS

fashion

author：explore 2025-09-27 10:05:30 - browse：596

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Hepatitis C has a cure — but many Americans still lack access to it

Wikipedia

WSS

Malaria cases in Florida and Texas: Here’s what you need to know

At least 13 dead in Texas as scorching temps continue

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Apple is now the first public company to be valued at $3 trillion

Duchenne breakthrough therapy leaves behind pioneering families

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

knowledge

fashion

focus

Moonlake's readout produced a cash windfall. Risks remain

Rock icon Freddie Mercury pre

The high cost of giving birth even with insurance

The cancer drug shortage isn’t new — and neither are the solutions

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

After affirmative action ruling, medical educators look to 'holistic review'

In Memoriam: Notable people who died in 2023

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Apple is now the first public company to be valued at $3 trillion

New company forms to vet health AI models, root out weaknesses

hotspot

Does Medicare's free annual wellness visit do any good?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Alkermes shareholders re

FDA approval of Sarepta Duchenne genetic therapy gives me hope

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

explore

Wikipedia

leisure time

focus